L'Oréal finalizes the acquisition of CeraVe, AcneFree and Ambi

FR
EN
Clichy, New York – 6 March 2017

L'Oréal finalizes the acquisition of CeraVe, AcneFree and Ambi

image
Clichy, New York – 6 March 2017 L’Oréal announced that it has finalized today the acquisition from Valeant of skincare brands CeraVe, AcneFree and Ambi

Developed with dermatologists, CeraVe, one of the fastest growing skincare brands in the United States, offers a range of advanced products, specifically cleansers, moisturizers, sunscreens, healing ointments and a dedicated baby line.  
AcneFree markets and distributes a full range of OTC cleansers and acne treatments, Ambi distributes skincare products formulated for the needs of multicultural consumers. 

The 3 brands are distributed in the United States in drug stores, mass and beauty retailers and select online outlets.
 

About L'Oréal
L’Oréal has devoted itself to beauty for over 100 years. With its unique international portfolio of 34 diverse and complementary brands, the Group generated sales amounting to 25.8 billion euros in 2016 and employs 89,300 people worldwide. As the world’s leading beauty company, L’Oréal is present across all distribution networks: mass market, department stores, pharmacies and drugstores, hair salons, travel retail, branded retail and e-commerce.
Research and innovation, and a dedicated research team of 3,870 people, are at the core of L’Oréal’s strategy, working to meet beauty aspirations all over the world. L’Oréal’s sustainability commitment for 2020 “Sharing Beauty With All” sets out ambitious sustainable development objectives across the Group’s value chain. www.loreal.com


"This news release does not constitute an offer to sell, or a solicitation of an offer to buy L'Oréal shares. If you wish to obtain more comprehensive information about L'Oréal, please refer to the public documents registered in France with the Autorité des Marchés Financiers, also available in English on our Internet site www.loreal-finance.com.
This news release may contain some forward-looking statements. Although the Company considers that these statements are based on reasonable hypotheses at the date of publication of this release, they are by their nature subject to risks and uncertainties which could cause actual results to differ materially from those indicated or projected in these statements."

Contacts at L'Oréal

Individual shareholders and market authorities
Mr Jean Régis CAROF
Tel.: +33 1 47 56 83 02
jean-regis.carof@loreal.com 

Financial analysts and Institutional investors 
Mrs Françoise LAUVIN
Tel.: +33 1 47 56 86 82
francoise.lauvin@loreal.com 
 
Journalists
Mrs Sophie DORY-LAUTREC
Tel.: +33 1 47 56 79 57
sophie.dorylautrec@loreal.com     

Switchboard
Tel.: +33 1 47 56 70 00

For more information, please contact your bank, broker or financial institution (I.S.I.N. code: FR0000120321), and consult your usual newspapers, the Internet site for shareholders and investors, www.loreal-finance.com, or the L'Oréal Finance mobile app, alternatively, call +33 1 40 14 80 50.


Read the news release of 10 January 2017: "L'Oréal signs agreement with Valeant to acquire CeraVe and two other brands"